TABLE 3.
Difference in Vessel Density and Foveal Avascular Zone Parameters From Macular Scans After Timolol Use, After Latanoprostene Bunod Use, and Between Timolol and Latanoprostene Bunod Use
| Timolol vs Baseline | P Value | LBN vs Baseline | P Value | LBN vs Timolol | P Value | |
|---|---|---|---|---|---|---|
|
| ||||||
| Vessel density (%) (95% CI) | ||||||
| Wi (wiVD) | −0.03 (−0.58 to 0.53) | .92 | 0.76 (0.20–1.33) | .009a | 0.70 (0.10–1.29) | .02a |
| Wi superior hemi | −0.14 (−0.72 to 0.43) | .63 | 0.80 (0.22–1.38) | .007a | 0.86 (0.25–1.47) | .006a |
| Wi inferior hemi | 0.10 (−0.47 to 0.66) | .74 | 0.72 (0.14–1.29) | .02a | 0.51 (−0.11 to 1.13) | .11 |
| Para fovea | 0.08 (−0.68 to 0.85) | .83 | 0.86 (0.05–1.66) | .04a | 0.63 (−0.27 to 1.53) | .17 |
| Para superior hemi | 0.07 (−0.75 to 0.89) | .86 | 1.17 (0.32–2.02) | .007a | 0.98 (0.02–1.93) | .047a |
| Para inferior hemi | 0.10 (−0.71 to 0.91) | .81 | 0.54 (−0.35 to 1.43) | .24 | 0.28 (−0.70 to 1.26) | .57 |
| Quadrant parafoveal vessel density (%) (95% CI) | ||||||
| Temporal | −0.09 (−0.91 to 0.73) | .83 | 0.81 (−0.03 to 1.64) | .06 | 0.70 (−0.22 to 1.63) | .14 |
| Superior | −0.11 (−0.97 to 0.75) | .80 | 1.04 (0.10–1.97) | .03a | 1.03 (0.02–2.05) | .048a |
| Nasal | 0.22 (−0.73 to 1.16) | .66 | 0.87 (−0.11 to 1.86) | .08 | 0.56 (−0.58 to 1.70) | .34 |
| Inferior | 0.35 (−0.54 to 1.24) | .45 | 0.71 (−0.25 to 1.67) | .15 | 0.23 (−0.88 to 1.33) | .69 |
| Foveal avascular zone (mm2) (95% CI) | ||||||
| Area | 0.00 (−0.01 to 0.01) | .73 | −0.00 (−0.01 to 0.01) | .90 | −0.00 (−0.01 to 0.01) | .48 |
| Perimeter | −0.01 (−0.04 to 0.03) | .69 | −0.02 (−0.05 to 0.02) | .41 | −0.01 (−0.05 to 0.03) | .53 |
| FD 300 area density | 0.17 (−0.69 to 1.02) | .77 | 0.26 (−0.60 to 1.11) | .56 | 0.09 (−0.95 to 1.13) | .87 |
CI = confidence interval; LBN = latanoprostene bunod; wi = whole image; FD 300 area density = density in the area within 300 μm from the foveal avascular zone boundary; VD =vessel density.
Statistically significant (P < .05).